Prolongation of the cardiac QTc interval in Turner syndrome

Medicine

Volumn 85, Issue 2, 2006, Pages 75-81

  Bondy, Carolyn A ^a   Van, Phillip L ^a   Bakalov, Vladimir K ^a   Sachdev, Vandana ^b   Malone, Carol A ^b   Ho, Vincent B ^c,d   Rosing, Douglas R ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY BUILD; CLINICAL FEATURE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; ECG ABNORMALITY; ELECTROCARDIOGRAM; FEMALE; HEART BLOCK; HEART MUSCLE CONDUCTION DISTURBANCE; HEART PREEXCITATION; HEART REPOLARIZATION; HEART SIZE; HUMAN; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; METABOLISM; PR INTERVAL; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; ST SEGMENT; STATISTICAL SIGNIFICANCE; T WAVE; TURNER SYNDROME;

ADOLESCENT; ADULT; AGED; BLOOD PRESSURE; BODY HEIGHT; BODY MASS INDEX; CARDIOVASCULAR ABNORMALITIES; CASE-CONTROL STUDIES; CHILD; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; HEART; HEART CONDUCTION SYSTEM; HEART VENTRICLES; HUMANS; MIDDLE AGED; TURNER SYNDROME;

EID: 33645897348     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.md.0000205629.16302.bc     Document Type: Article

References (37)

1. Bazett J. An analysis of time relation of electrocardiograms. Heart. 1920;7:353-367.
2. Bechtold SM, Dalla Pozza R, Becker A, Meidert A, Dohlemann C, Schwarz HP. Partial anomalous pulmonary vein connection: an underestimated cardiovascular defect in Ullrich-Turner syndrome. Eur J Pediatr. 2004;163:158-162.
3. Brown D, Giles W, Greenlund K, Rodolfo V, Croft J. Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated with prolonged QTc duration. Results from the Third National Health and Nutrition Examination Survey. J Cardiovasc Risk. 2001;8:227-233.
4. Casale P, Devereux R, Kligfield P, Eisenberg RR, Miller DH, Chaudhary BS, Phillips MC. Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am Coll Cardiol. 1985;6:572-580.
5. Clark EB. Neck web and congenital heart defects: a pathogenic association in 45 X-O Turner syndrome. Teratology. 1984;29:355-361.
6. Cooley M, Bakalov V, Bondy CA. Lipid profiles in women with 45,X vs 46,XX primary ovarian failure. JAMA. 2003;290:2127-2128.
7. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol. 1992;20:1251-1260.
8. Dekker JM, Crow RS, Hannan PJ, Schouten EG, Folsom AR. Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middle-aged men and women: the ARIC study. J Am Coll Cardiol. 2004;43:565-571.
9. Devereux R, Alonso D, Lutas E, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-458.
10. Elsheikh M, Dunger DB, Conway GS, Wass JA. Turner's syndrome in adulthood. Endocr Rev. 2002;23:120-140.
11. Gotzsche C, Krag-Olsen B. Prevalence of cardiovascular malformations and association with karyotypes in Turner's syndrome. Arch Dis Child. 1994;71:433-436.
12. Gravholt CH, Juul S, Naeraa RW, Hansen J. Morbidity in Turner syndrome. J Clin Epidemiol. 1998;51:147-158.
13. Ho VB, Bakalov VK, Cooley M, Van PL, Hood MN, Burklow TR, Bondy CA. Major vascular anomalies in Turner syndrome: prevalence and magnetic resonance angiographic features. Circulation. 2004;110:1694-1700.
14. Landin-Wilhelmsen K, Bryman I, Wilhelmsen L. Cardiac malformations and hypertension, but not metabolic risk factors, are common in Turner syndrome. J Clin Endocrinol Metab. 2001;86:4166-4170.
15. Lee S, Harris ND, Robinson RT, Yeoh L, Macdonald IA, Heller SR. Effects of adrenaline and potassium on QTc interval and QT dispersion in man. Eur J Clin Invest. 2003;33:93-98.
16. Leroy SS, Russell M. Long QT syndrome and other repolarization-related dysrhythmias. AACN Clin Issues. 2004;15:419-431.
17. Linnemann B, Janka HU. Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study. Exp Clin Endocrinol Diabetes. 2003;111:215-222.
18. Lippe B. Turner syndrome. Endocrinol Metab Clin North Am. 1991;20:121-152.
19. Mangoni AA, Kinirons MT, Swift CG, Jackson SH. Impact of age on QT interval and QT dispersion in healthy subjects: a regression analysis. Age Ageing. 2003;32:326-331.
20. Mazzanti L, Cacciari E. Congenital heart disease in patients with Turner's syndrome. Italian Study Group for Turner Syndrome (ISGTS). J Pediatr. 1998;133:688-692.
21. Micromedex Healthcare Series, Vol. 121. Greenwood Village, CO: Thomson Micromedex; 2004.
22. Morganroth J. Relations of QTc prolongation on the electrocardiogram to torsades de pointes: definitions and mechanisms. Am J Cardiol. 1993;72:10B-13B.
23. Nathwani NC, Unwin R, Brook CG, Hindmarsh PC. Blood pressure and Turner syndrome. Clin Endocrinol (Oxf). 2000;52:363-370.
24. Nielsen J, Wohlert M. Sex chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Birth Defects Orig Artic Ser. 1990;26:209-223.
25. Okin PM, Devereux RB, Lee ET, Galloway JM, Howard BV. Electrocardiographic repolarization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes: the strong heart study. Diabetes. 2004;53:434-440.
26. Pashmforoush M, Lu J, Chen H, Amand T, Kondo R, Pradervand S, Evans S, Clark B, Feramisco J, Giles W, Ho S, Benson D, Silberbach M, Shou W, Chien K. Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell. 2004;117:373-386.
27. Passino C, Franzoni F, Gabutti A, Poletti R, Galetta F, Emdin M. Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy. Int J Cardiol. 2004;97:57-62.
28. Piccini M, Vitelli F, Seri M, Galietta LJ, Moran O, Bulfone A, Banfi S, Pober B, Renieri A. KCNE1-like gene is deleted in AMME contiguous gene syndrome: identification and characterization of the human and mouse homologs. Genomics. 1999;60:251-257.
29. Prandstraller D, Mazzanti L, Picchio F, Magnani C, Bergamaschi R, Perri A, Tsingos E, Cacciari E. Turner's syndrome: cardiologic profile according to the different chromosomal patterns and long-term clinical follow-up of 136 nonpreselected patients. Pediatr Cardiol. 1999;20:108-112.
30. Priori SG. Inherited arrhythmogenic diseases: the complexity beyond monogenic disorders. Circ Res. 2004;94:140-145.
31. Robbins J, Nelson JC, Rautaharju PM, Gottdiener JS. The association between the length of the QT interval and mortality in the Cardiovascular Health Study. Am J Med. 2003;115:689-694.
32. Romhilt DW, Estes EH. A point-score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J. 1968;75:752-759.
33. Schiller N, Shah P, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358-367.
34. Sokolow M, Lyon T. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949;37:161-186.
35. Surawicz B, Parikh SR. Differences between ventricular repolarization in men and women: description, mechanism and implications. Ann Noninvasive Electrocardiol. 2003;8:333-340.
36. University of Arizona Center for Education and Research on Therapeutics Website. For professionals: Drug lists (by risk groups). Drug list updates. Available at: http://www.arizonacert.org/medical-pros/drug-lists/drug-lists.htm. Accessed January 2005.
37. White WB, Susser W, James GD, Marra L, McCabe EJ, Pickering TG, Streeten DH. Multicenter assessment of the QuietTrak ambulatory blood pressure recorder according to the 1992 AAMI guidelines. Am J Hypertens. 1994;7:509-514.